Regenxbio Inc Revenue per Employee (RGNX), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Regenxbio Inc   (NASDAQ: RGNX)
 

Regenxbio Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Regenxbio Inc 's Revenue per employee fell on a trailing twelve month basis to $ 414,854, but the productivity of Regenxbio Inc 's employees remained above the company average.
Within the Healthcare sector Employees of 364 other companies have achieved higher revenue per employee. While Regenxbio Inc 's total ranking has deteriorated compared to the previous quarter from 2503 to 2829. Regenxbio Inc has 371 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

RGNX Revenue per Employee (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Revenue Change -69.19 % 405.73 % -92.82 % 43 % 22.88 %
Sales per Employee (TTM) $ 414,854 470,302 236,717 459,410 434,819
RGNX's Total Ranking # 2829 # 2503 # 1331 # 908 #
Seq. Revenue Change -91.52 % 1589.64 % -78.93 % 2.03 % 39.21 %

RGNX Company Profile >> Back to RGNX Efficiency Comparisons >> Compare RGNX Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 43
Healthcare Sector # 365
Overall Market # 2829

Revenue per Employee Statistics
High Average Low
$ 1,305,377 $ 345,797 $ 12,369
(Jun 30 2022)   (Dec 31 2016)



Financial Statements
Regenxbio Inc 's Revenue MRQ $ 9 Millions Visit RGNX's Income Statement
Regenxbio Inc 's Revenues TTM $ 154 Millions Visit RGNX's aggregate revenue growth
What are RGNX's Sales? Visit RGNX's Sales by Segment




Other Ratios
Regenxbio Inc 's Income per Employee
Employees in Biotechnology & Pharmaceuticals
Biotechnology & Pharmaceuticals Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
RGNX's Revenue per Employee versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for RGNX's Competitors
Revenue per Employee for RGNX's Suppliers
Revenue per Employee for RGNX's Customers

You may also want to know
RGNX's Sales Growth Rates RGNX's Pe Price to earnings ratio RGNX's Receivables Turnover Ratio RGNX's Stock Quote
RGNX's Net Income Growth Rates RGNX's Ps Price to Sales ratio RGNX's Sales per Employee RGNX's Asset Turnover Ratio
RGNX's Net Margin RGNX's Pb Price to Book ratio RGNX's Financial Strength Ratios RGNX's Dividend Payout Ratio
Date modified: 2026-11-09T18:44:19+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2026Number of Employees Sep 30 2026
Xilio Therapeutics Inc   723,815.79 $ 55.010  Million 76 
Emergent Biosolutions Inc   721,222.22 $ 649.100  Million 900 
Intuitive Surgical Inc   711,803.07 $ 12,115.600  Million 17,021 
Waters Corporation  710,298.99 $ 5,611.362  Million 7,900 
Johnson and Johnson  705,504.26 $ 99,335.000  Million 140,800 
Mannkind Corporation  698,260.14 $ 413.370  Million 592 
Ionis Pharmaceuticals Inc   684,801.00 $ 960.091  Million 1,402 
Rhythm Pharmaceuticals Inc   678,135.27 $ 280.748  Million 414 
Inspire Medical Systems inc   661,810.95 $ 882.194  Million 1,333 
Caredx Inc   650,190.85 $ 497.396  Million 765 
Koru Medical Systems Inc   633,862.01 $ 46.272  Million 73 
Organon and Co   611,100.00 $ 6,111.000  Million 10,000 
Bioventus Inc   609,707.29 $ 585.319  Million 960 
Si bone inc   590,928.19 $ 222.189  Million 376 
Coya Therapeutics Inc   586,128.13 $ 4.689  Million 8 
Butterfly Network Inc   562,340.91 $ 123.715  Million 220 
Carlsmed Inc   559,716.54 $ 71.084  Million 127 
Beone Medicines Ltd   550,523.25 $ 6,606.279  Million 12,000 
Novavax inc   549,598.13 $ 411.649  Million 749 
Henry Schein Inc   549,360.00 $ 13,734.000  Million 25,000 
Bausch Health Companies Inc   547,438.42 $ 11,113.000  Million 20,300 
Iradimed Corporation  538,192.16 $ 89.340  Million 166 
Glaukos Corp  528,660.88 $ 578.355  Million 1,094 
Alpha Pro Tech Ltd   527,967.48 $ 64.940  Million 123 
Orthofix Medical Inc   520,674.77 $ 835.683  Million 1,605 
Angiodynamics Inc   512,316.46 $ 323.784  Million 632 
Resmed Inc   505,115.57 $ 5,743.164  Million 11,370 
Cardiff Lexington Corporation  503,682.17 $ 9.066  Million 18 
Avantor Inc   491,525.93 $ 6,635.600  Million 13,500 
Gossamer Bio Inc   484,092.59 $ 78.423  Million 162 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.